Alnylam Pharmaceuticals Inc (ALNY) earnings · P/E 39, rev $3.71B
These earnings events as JSON? API free 100/dayAlnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
This ALNY earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ALNY revenue for 2025-12-31 was $3.71B. Net income was $313.7M. Revenue was up 65.2% from 2024-12-31 to 2025-12-31. ALNY currently screens at market cap $40.46B and trailing P/E 39.3.
When the next ALNY 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 65.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ALNY research stays on the stock page; the tape stays on the quote page.
ALNY earnings FAQ
What are ALNY's latest revenue and net income?
Latest cached Alnylam Pharmaceuticals Inc (ALNY) revenue for Dec 31, 2025 was $3.71B. Net income was $313.7M. Statements: https://lician.com/financials/alny
What is ALNY's latest diluted EPS?
Latest cached Alnylam Pharmaceuticals Inc (ALNY) diluted EPS for Dec 31, 2025 was $2.33.
What period does the latest ALNY earnings print cover?
The latest cached Alnylam Pharmaceuticals Inc (ALNY) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ALNY revenue change from the prior cached period?
Cached Alnylam Pharmaceuticals Inc (ALNY) revenue was up 65.2% from $2.25B (Dec 31, 2024) to $3.71B (Dec 31, 2025). Statements: https://lician.com/financials/alny
What is ALNY's P/E ratio?
Alnylam Pharmaceuticals Inc (ALNY) trailing P/E is 39.3 on the latest cached fundamentals snapshot.
Where are ALNY earnings listed?
Cached earnings facts for Alnylam Pharmaceuticals Inc (ALNY) are listed at https://lician.com/earnings/alny. Statements: https://lician.com/financials/alny
Not investment advice.